Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders
Year: 2012
Type: review
Abstract: Matrix metalloproteinases (MMPs) are a subfamily of zinc-dependent proteases that are responsible for degradation and remodeling of extracellular matrix proteins. The activity of MMPs is tightly regulated at several levels including cleavage of prodomain, allosteric activation, compartmentalization and complex formation with tissue inhibitor of metalloproteinases (TIMPs). In the central nervous system (CNS), MMPs play a wide variety of roles ranging from brain development, synaptic plasticity and repair after injury to the pathogenesis of various brain disorders. Following general discussion on the domain structure and the regulation of activity of MMPs, we emphasize their implication in various brain disorder conditions such as Alzheimer's disease, multiple sclerosis, ischemia/reperfusion and Parkinson's disease. We further highlight accumulating evidence that MMPs might be the culprit in Parkinson's disease (PD). Among them, MMP-3 appears to be involved in a range of pathogenesis processes in PD including neuroinflammation, apoptosis and degradation of α-synuclein and DJ-1. MMP inhibitors could represent potential novel therapeutic strategies for treatments of neurodegenerative diseases.
Source: Biomolecules & Therapeutics
Authors: Yoon-Seong Kim, Tong-H. Joh
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: matrix metalloproteinases, neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, multiple sclerosis, ischemia-reperfusion, MMP-3, tissue inhibitors of metalloproteinases, extracellular matrix remodeling, neuroinflammation, apoptosis, alpha-synuclein degradation, DJ-1, matrix metalloproteinase inhibitors, synaptic plasticity
Open Access status: bronze
OpenAlex ID: W2033836926
